JPRN-UMIN000034986招募中2 期
Stiripentol for the treatment of pharmacoresistant epilepsy with drug eruptions - STP for pharmacoresistant epilepsy with drug eruptions
Department of Neurology, Nagoya City University0 个研究点目标入组 20 人开始时间: 2018年11月25日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 16years-old 至 90years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Others than those above
研究者
相似试验
招募中
不适用
Stiripentol (diacomit(R)) for refractory epilepsy patients with autoimmune encephalitisrefractory epilepsyJPRN-UMIN000023741agoya City University6
进行中（未招募）
不适用
Addition of spironolactone in patients with resistant arterial hypertension (ASPIRANT) - ASPIRANTEUCTR2007-003558-27-CZOlomouc University Hospital and Palacký University School of Medicine, Internal Medicine Dept. I160
已完成
不适用
INEZOLID FOR THE TREATMENT OF METHICILIN RESISTANT STAPHYLOCOCCUS AUREUS (MRSA) INFECTIONS: AN EVALUATOR-BLINDED TRIAL COMPARING LINEZOLID WITH VANCOMYCIN ALONE AND VANCOMYCIN FOLLOWED BY ORAL LINEZOLID-A410 Sepsis due to Staphylococcus aureusSepsis due to Staphylococcus aureusA410PER-009-98PHARMACIA & UPJOHN INTERAMERICAN CORPORATION,
招募中
1 期
PiSCATIN - Simvastatin for the treatment of primary sclerosing cholangitis (PSC) - a randomized double-blind, placebo-controlled multicenter studyCTIS2024-511053-22-00Karolinska University Hospital560
已完成
3 期
SertraLine administration to prevent intrAdialytic hypotension: A randomized, double-blinded, placebo-controlled, crossover studyHemodialysis patients who have history of intradialytic hypotensionIntradialytic hypotensionChronic hemodialysisSertralineHemodialysis complicationTCTR20181002002Renal Division, Department of Internal Medicine, Faculty of Medicine, Chiang Mai University40